Multiomic Health https://validator.w3.org/feed/docs/rss2.html A paper by the MultiOmic team members was published in the May issue of the ICT magazine Board. Careers. Pipeline. Team. MultiOmic Health to Present at Bio€quity Europe 2024 MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease Delivering precision medicines for chronic multifactorial diseases Investors. Verve Ventures Hoxton Ventures Ada Ventures MMC Ventures MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease Understanding the AI-enabled Drug Discovery Landscape Leveraging AI to Tackle the Looming Metabolic Syndrome Crisis Leveraging deep omics data to tackle a global health challenge with precision Privacy Notice. PhD Studentship Approach. Home The Pharma Letter Podcast — Episode 15 — Can AI find new drugs for metabolic diseases? MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines and Diagnostics for Chronic Metabolic Disease News. MultiOmic Health and BIO4 Campus Sign MoU to Advance Precision Medicine and Support Bioeconomy Growth in Serbia MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs Formic Ventures HOF Capital Fifty Years Advisors. Curiosity. Honoured to be selected as winners of BIA’s Innovation Showcase in the first ever TechBioUK conference MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions MultiOmic Health presents at LSX Investival 2024 Selvedge Venture